Dow Down 0.62% Nasdaq Down 1.14%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLineRx, Ltd. (BLRX)

-NasdaqCM
1.51 Down 0.05(3.21%) Sep 22, 3:59PM EDT
Prev Close:1.56
Open:1.56
Bid:N/A
Ask:1.66 x 7700
1y Target Est:7.33
Beta:3.09
Next Earnings Date:N/A
Day's Range:1.49 - 1.59
52wk Range:1.49 - 3.34
Volume:107,317
Avg Vol (3m):82,061
Market Cap:51.51M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BLRX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback